top of page
Pioneering Non-Invasive Solutions for Neurological Disease Management
Blinkcns utilizes the blink reflex using its FDA-cleared EyeStat device—a 30-second, non-invasive test that delivers faster, objective data for neurological assessment and disease management, empowering earlier detection, personalized care, and improved patient care and outcomes.
A Game-Changer in Neurology
Introducing EyeStat5, the next generation of the world's first FDA-cleared technology indicated to measure and assess the blink reflex.
*EyeStat5 is pending FDA clearance
Blinkcns has expanded its technology and will be used both in a clinical and telehealth (e.g., athletic facility or in-home) setting. Our i-blink app for clinicians and patients will be available on iPhone and Android mobile devices. This innovation enables low-cost and objective capturing of spontaneous and stimulated blinking for enhanced neurological management.
Our Clinical and Research Partners
.png)
bottom of page